Legend Biotech Corp Cash Flows From Used In Operating Activities
Legend Biotech Corp (LEGN) reported Cash Flows From Used In Operating Activities of -$100.20 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2026-03-10
- Legend Biotech Corp cash flows from used in operating activities for the quarter ending 2025-12-31 was -$12.21M.
- Legend Biotech Corp cash flows from used in operating activities for the quarter ending 2025-09-30 was $28.80M.
- Legend Biotech Corp cash flows from used in operating activities for the quarter ending 2025-06-30 was -$13.04M.
- Legend Biotech Corp cash flows from used in operating activities for the quarter ending 2025-03-31 was -$103.75M, a 768.60% decline year-over-year.
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 12 month | Cash Flows From Used In Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$12.21M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $16.60M derived: sum of 2 quarters · filed 2026-03-10 | $3.55M derived: sum of 3 quarters · filed 2026-03-10 | -$100.20M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $28.80M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $15.76M derived: sum of 2 quarters · filed 2025-11-12 | -$88.00M 6-K · filed 2025-11-12 | -$170.04M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | -$13.04M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | -$116.80M 6-K · filed 2025-08-11 | -$198.84M derived: sum of 3 quarters · filed 2026-03-10 | -$274.66M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | -$103.75M 6-K · filed 2025-05-13 | -$185.80M derived: sum of 2 quarters · filed 2026-03-10 | -$261.62M derived: sum of 3 quarters · filed 2026-03-10 | -$263.27M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | -$82.05M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$157.87M derived: sum of 2 quarters · filed 2026-03-10 | -$159.52M derived: sum of 3 quarters · filed 2026-03-10 | -$144.00M 20-F · filed 2026-03-10 | -$144.03M 20-F · filed 2025-03-11 |
| 2024-09-30 | -$75.82M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -$77.47M derived: sum of 2 quarters · filed 2025-11-12 | -$61.95M 6-K · filed 2025-11-12 | -$157.62M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | -$1.65M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $13.87M 6-K · filed 2025-08-11 | -$81.80M derived: sum of 3 quarters · filed 2026-03-10 | -$142.65M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $15.52M 6-K · filed 2025-05-13 | -$80.15M derived: sum of 2 quarters · filed 2026-03-10 | -$141.00M derived: sum of 3 quarters · filed 2026-03-10 | -$238.57M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | -$95.67M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$156.52M derived: sum of 2 quarters · filed 2026-03-10 | -$254.09M derived: sum of 3 quarters · filed 2026-03-10 | -$393.30M 20-F · filed 2026-03-10 | -$393.28M 20-F · filed 2024-03-19 |
| 2023-09-30 | -$60.85M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$158.42M derived: sum of 2 quarters · filed 2024-11-12 | -$297.63M 6-K · filed 2024-11-12 | -$347.37M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | -$97.57M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$236.78M 6-K · filed 2024-08-09 | -$286.52M derived: sum of 3 quarters · filed 2025-03-11 | -$358.64M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | -$139.22M 6-K · filed 2024-05-13 | -$188.96M derived: sum of 2 quarters · filed 2025-03-11 | -$261.07M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | -$49.74M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | -$121.85M derived: sum of 2 quarters · filed 2025-03-11 | -$201.28M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | -$72.11M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | -$151.54M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | -$79.43M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | -$198.47M 20-F · filed 2024-03-19 | ||||
| 2021-06-30 | -$84.33M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | -$223.00M 20-F · filed 2023-03-30 | ||||
| 2020-06-30 | -$102.68M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | -$83.06M 20-F/A · filed 2023-02-17 | ||||
| 2018-12-31 | $307.68M 20-F · filed 2021-04-02 |